×
A $62 billion monument to “futile competition” exists in healthcare. Drug companies spend 24% of revenue on marketing versus 13% on R&D. Prescription decisions should be based on objective medical criteria and public data. Spending so much on armies of salespeople is tree-trunk logic: No company can risk not playing the game. However, a neutral body empowered to enforce agreed limits could change the game and achieve marketing disarmament. Whatever information salespeople provide could be put online for a tiny fraction of today’s $74,000 per doctor (and reduce nonmedical distortions). - http://bigthink.com/errors-we-live-by/how-free-competition-can-create-dumb-costs